Skip to content

Obstructive Sleep Apnoea in Ehlers-Danlos Syndrome

Obstructive Sleep Apnoea in Ehlers-Danlos Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02435745
Acronym
OSA in EDS
Enrollment
200
Registered
2015-05-06
Start date
2015-04-30
Completion date
2015-12-31
Last updated
2015-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ehlers-Danlos Syndrome, Obstructive Sleep Apnea

Keywords

Ehlers-Danlos Syndrome, Obstructive Sleep Apnea, Prevalence, Aortic Aneurysm

Brief summary

Ehlers-Danlos Syndrome (EDS) is a clinically and genetically heterogeneous group of inherited connective tissue disorders characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. EDS features such as genetically related cartilage defects, craniofacial abnormalities and increased pharyngeal collapsibility have been proposed to cause obstructive sleep apnoea (OSA). There is evidence from studies based on questionnaires that EDS patients might be more frequently affected by OSA and sleep disturbances than the general population. However, the actual prevalence of OSA in patients with EDS is unknown. Aortic root dilation and dissection are common complications of EDS and little is known about the underlying risk factors. Preliminary evidence suggests a link with OSA but this has not yet been investigated. The primary objective of this study is to assess the prevalence of OSA in EDS-patients (100) compared to a matched control group (100). The secondary objective of this pioneer study is to assess whether there is a relationship between OSA severity and aortic diame-ter/craniofacial abnormalities in EDS patients.

Detailed description

Ehlers-Danlos Syndrome (EDS) is a clinically and genetically heterogeneous group of inherited connective tissue disorders characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. EDS features such as genetically related cartilage defects, craniofacial abnormalities and increased pharyngeal collapsibility have been proposed to cause obstructive sleep apnoea (OSA). There is evidence from studies based on questionnaires that EDS patients might be more frequently affected by OSA and sleep disturbances than the general population. However, the actual prevalence of OSA in patients with EDS is unclear. Aortic dilation and dissection are complications associated with EDS and little is known about the underlying risk factors. Preliminary evidence suggests a link with OSA but this has not yet been investigated. The primary objective of this study is to assess the prevalence of OSA in EDS-patients compared to a matched control group. The secondary objective of the study is to assess whether there is a relationship between OSA severity and craniofacial phenotypes / aortic diameter in EDS patients.

Interventions

None listed

Sponsors

University Children's Hospital, Zurich
CollaboratorOTHER
Ehlers-Danlos Network, Switzerland
CollaboratorOTHER
University of Zurich
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Informed consent * Diagnosis of Ehlers-Danlos Syndrome (not for control group)

Exclusion criteria

* Moribund or severe disease prohibiting protocol adherence * Continuous positive airway pressure treatment for OSA during sleep study * Physical or intellectual impairment precluding informed consent or protocol adherence * Pregnant patients

Design outcomes

Primary

MeasureTime frame
Prevalence of OSAup to 12 months

Secondary

MeasureTime frame
Craniofacial phenotypingup to 12 months
Aortic diameterup to 12 months

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026